6505--Zolmitriptan Tablets (VA-25-00006129)
ID: 36E79724R0028Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/82ca2b61a0b545fe9bb08f948c4d2a9a/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting bids for the procurement of Zolmitriptan tablets, as outlined in solicitation number VA-25-00006129. This contract aims to establish a reliable source of pharmaceutical supplies for federal healthcare programs, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and good manufacturing practices as mandated by the FDA. The selected contractor will be responsible for providing competitive pricing for both the base year and four option years, ensuring that all products meet safety and regulatory standards. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details and to discuss submission requirements.

    Point(s) of Contact
    Kenneth LayContract Specialist
    Kenneth.Lay@va.gov
    Files
    Title
    Posted
    36E79724R0028_1.docx
    The Department of Veterans Affairs (VA) National Acquisition Center is initiating a Request for Proposal (RFP 36E79724R0028) for Zolmitriptan Tablets. This procurement targets an unrestricted supply of the medication for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. One contract will be awarded to ensure continuous availability of the specified product, with a contract term of one year plus four optional one-year extensions. The estimated annual requirements include 28,339 blister packs of Zolmitriptan 2.5mg (6 tablets per pack) and 147,600 blister packs of Zolmitriptan 5mg (3 tablets per pack). The solicitation will be issued electronically on or around September 5, 2024, with a submission deadline of September 19, 2024. Interested vendors must have an FDA-assigned NDC number and can check for updates or amendments on sam.gov. The primary point of contact for inquiries regarding this procurement is Contract Specialist Kenneth Lay, reachable via email at Kenneth.Lay@va.gov. The VA emphasizes the importance of reliable supply and compliance with federal procurement regulations for this pharmaceutical contract.
    36E79724R0028.docx
    The document outlines a government solicitation for pharmaceutical supplies specifically focused on Zolmitriptan tablets for the Department of Veterans Affairs and the Department of Defense. Key elements include contract details such as solicitation number, award date, delivery terms, and qualifications for bidders, emphasizing the requirement for prices for both the base year and four option years while ensuring compliance with the Drug Supply Chain Security Act (DSCSA). Offerors must submit unique National Drug Codes (NDC) for their products and demonstrate adherence to good manufacturing practices as mandated by the FDA. The solicitation also incorporates clauses related to contract terms and conditions, performance evaluations, subcontracting plans, and reporting obligations, focusing on maintaining a reliable supply chain and ensuring that products meet safety and regulatory standards. The overarching goal is to establish a consistent source for pharmaceutical needs within federal healthcare programs, seeking competitive pricing and compliance with established legal frameworks. The structure includes multiple sections detailing requirements, evaluations, and necessary documentation for potential contractors.
    Lifecycle
    Title
    Type
    6505--Zolmitriptan Tablets (VA-25-00006129)
    Currently viewing
    Solicitation
    6505--Zolmitriptan Tablets (VA-25-00006129)
    Presolicitation
    Similar Opportunities
    Rizatriptan Benzoate
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Rizatriptan Benzoate tablets. The contract will establish a national supply source to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The solicitation will be posted on the DLA Bid Board System and SAM.gov. Interested parties should contact Keith Ryales for any questions/comments. The projected solicitation date is June 2022.
    6505--Baclofen Tablets (VA-25-00026620)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Baclofen tablets through its Pharmaceutical Prime Vendor Program, with the solicitation titled "6505--Baclofen Tablets (VA-25-00026620)." The primary objective of this procurement is to establish a reliable source for various strengths of Baclofen tablets, ensuring consistent availability and quality at pre-negotiated prices, while also requiring compliance with the Drug Supply Chain Security Act and Good Manufacturing Practices as evaluated by the FDA. This contract is crucial for maintaining the supply of necessary pharmaceuticals across VA facilities, addressing issues related to compliance, backorders, and recalls. Interested offerors must submit their bids, including pricing for the base year and four one-year options, along with a 0.5% Cost Recovery Fee, and can direct inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--Nadolol Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of Nadolol tablets as part of its Pharmaceutical Prime Vendor Program. This solicitation requires bidders to provide various dosages of Nadolol, along with unique National Drug Codes (NDCs), and to adhere to strict compliance with federal manufacturing practices and regulations, including the Drug Supply Chain Security Act. The consistent supply of these pharmaceuticals is crucial for meeting the healthcare needs of veterans, ensuring they receive necessary medications without interruption. Interested parties should contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further details, and must adhere to the submission requirements outlined in the solicitation document, which includes a 0.5% cost recovery fee and specific timelines for bid submission.
    6505--Tamsulosin Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--761-25-1-015-0002 -Chelmsford CMOP 7 PHARMACEUTICALS (VA-25-00012193)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply thirteen specific pharmaceuticals for delivery to the Chelmsford Consolidated Mail Outpatient Pharmacy (CMOP) in Massachusetts. The procurement includes items such as Clomiphene Citrate and various Amlodipine/Benzapril combinations, with strict requirements for compliance with the Drug Supply Chain Security Act and a minimum one-year shelf life upon delivery. This initiative is crucial for maintaining an adequate pharmaceutical inventory to support the healthcare needs of veterans. Interested vendors must submit their proposals by December 2, 2024, including a signed SF1449 form, a completed pricing schedule, proof of a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, directed to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Carbidopa/Levodopa SA Tablet
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) 36E79725R0008 for the procurement of Carbidopa/Levodopa sustained release (SA) tablets, aimed at ensuring a continuous supply of these medications for various federal health services, including the Department of Defense and the Bureau of Prisons. The contract will be awarded for an initial period of one year, with the option to extend for four additional one-year periods, requiring offerors to provide unique branding and packaging without overlapping labels. The estimated annual usage totals approximately 119,875 bottles across two dosage forms, highlighting the importance of these medications in treating Parkinson's disease and related conditions. Interested parties should note that the electronic solicitation is expected to be issued around January 3, 2026, with offers due by January 17, 2026; questions can be directed to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov.
    6505--762-25-1-040-0496 -Tucson CMOP MESALAMINE -(VA-25-00029547)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through its Network Contracting Office 15, is seeking proposals for the procurement of MESALAMINE 375MG SA capsules, specifically requiring 1,200 bottles (120 capsules each) for delivery to the Tucson CMOP facility. This solicitation, numbered 36C77025Q0098, is set aside for small businesses and aims to ensure the timely availability of essential pharmaceuticals for veterans' healthcare needs. Interested vendors must submit their offers, including a signed SF1449 form, a price schedule, proof of state wholesale distributor licensure, and a Buy American Act certificate, by January 21, 2025. Proposals should be directed to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov, with compliance to the Drug Supply Chain Security Act being a critical requirement for consideration.
    6505--761-25-1-015-0001 -Chelmsford CMOP Pharm -(VA-25-00012051)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Quotation (RFQ) for various pharmaceutical products to be supplied to the Chelmsford VA Center facility. The procurement includes items such as a vaginal gel, multivitamin tablets, and a wound therapy solution, with specific quantities and packaging requirements outlined for each product. This solicitation underscores the VA's commitment to ensuring a stable supply of essential medications for veterans while adhering to federal procurement regulations. Interested vendors must submit their quotations by January 17, 2025, and provide necessary documentation, including a state wholesale distributor license and OEM authorization, to the designated contract specialist, Lacie Nowak, at Lacie.nowak@va.gov.
    6505--Metformin SA Tablets REPACK PROGRAM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Metformin SA Tablets through its Repack Program, aimed at ensuring a stable supply of essential pharmaceuticals for veteran healthcare. Bidders are required to adhere to strict FDA good manufacturing practices, propose pricing that includes a 0.5% Cost Recovery Fee, and comply with the Drug Supply Chain Security Act regulations, among other requirements. This procurement is critical for maintaining the availability and quality of medications for veterans, reflecting the government's commitment to their healthcare needs. Interested contractors must submit their offers by January 21, 2025, at 2:30 PM CST, and can direct inquiries to Senior Contract Specialist Teresa Hussain at teresa.hussain@va.gov.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.